Impact of body mass index on plasma n-terminal prob-type natriuretic peptides in chinese atrial fibrillation patients without heart failure

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Zheng, Li Hui ^a   Wu, Ling Min ^a   Yao, Yan ^a   Chen, Wen Sheng ^a   Bao, Jing Ru ^a   Huang, Wen ^a   Shi, Rui ^a   Zhang, Kui Jun ^a   Zhang, Shu ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROPAFENONE; WARFARIN; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGED; ARTICLE; BODY MASS; CATHETER ABLATION; CLINICAL FEATURE; CLINICAL PRACTICE; CONTROLLED STUDY; DECISION MAKING; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PATHOPHYSIOLOGY; RADIOFREQUENCY ABLATION; ATRIAL FIBRILLATION; BLOOD; HEART FAILURE; MIDDLE AGED;

AGED; ATRIAL FIBRILLATION; BODY MASS INDEX; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OBESITY; PEPTIDE FRAGMENTS;

EID: 84928035151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105249     Document Type: Article

References (26)

1. Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, et al. (2003) The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89: 745-751. (Pubitemid 36760633)
2. Rivera M, Cortés R, Salvador A, Bertomeu V, de Burgos FG, et al. (2005) Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology. Eur J Heart Fail 7: 1168-1170. (Pubitemid 41721121)
3. Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, et al. (2005) Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 149: 744-750.
4. Hong SN, Ahn Y, Yoon NS, Moon JY, Kim KH, et al. (2008) N-terminal pro-B-type natriuretic peptide level is depressed in patients with significant coronary artery disease who have high body mass index. Int Heart J 49: 403-412.
5. Lorgis L, Cottin Y, Danchin N, Mock L, Sicard P, et al. (2011) Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction. Heart 97: 551-956.
6. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, et al. (2005) Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112: 2163-2168. (Pubitemid 41475811)
7. Cortés R, Otero MR, Morillas P, Roselló-Lletí E, Grigorian L, et al. (2008) Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels. Am J Hypertens 21: 820-825. (Pubitemid 351913611)
8. Patton KK, Ellinor PT, Heckbert SR, Christenson RH, DeFilippi C, et al. (2009) N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation 120: 1768-1774.
9. den Uijl DW, Delgado V, Tops LF, Ng AC, Boersma E, et al. (2011) Natriuretic peptide levels predict recurrence of atrial fibrillation after radiofrequency catheter ablation. Am Heart J 161: 197-203.
10. Deftereos S, Giannopoulos G, Kossyvakis C, Raisakis K, Kaoukis A, et al. (2011) Estimation of atrial fibrillation recency of onset and safety of cardioversion using NTproBNP levels in patients with unknown time of onset. Heart 97: 914-917.
11. Gibson PH, Croal BL, Cuthbertson BH, Rae D, McNeilly JD, et al. (2009) Use of preoperative natriuretic peptides and echocardiographic parameters in predicting new-onset atrial fibrillation after coronary artery bypass grafting: a prospective comparative study. Am Heart J 158: 244-251.
12. National Heart, Lung, and Blood Institute Expert Panel (1998) Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Evidence Report. Bethesda, Md: National Heart, Lung, and Blood Institute; June.
13. Sugisawa T, Kishimoto I, Kokubo Y, Makino H, Miyamoto Y, et al. (2010) Association of plasma B-type natriuretic peptide levels with obesity in a general urban Japanese population: the Suita Study. Endocr J 57: 727-733.
14. Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, et al. (2009) Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 54: 1599-1606.
15. Mollmann H, Weber M, Elsasser A, Nef H, Dill T, et al. (2008) NT-ProBNP predicts rhythm stability after cardioversion of lone atrial fibrillation. Circ J 72: 921-925. (Pubitemid 351879912)
16. Malavazos AE, Morricone L, Marocchi A, Ermetici F, Ambrosi B, et al. (2006) N-terminal pro-B-type natriuretic peptide and echocardiographic abnormalities in severely obese patients: correlation with visceral fat. Clin Chem 52: 1211-1213. (Pubitemid 43794447)
17. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, et al. (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109: 594-600. (Pubitemid 38198866)
18. Sengenès C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J (2000) Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 14: 1345-1351. (Pubitemid 30439743)
19. Sarzani R, Dessì-Fulgheri P, Paci VM, Espinosa E, Rappelli A (1996) Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 19: 581-585. (Pubitemid 26408098)
20. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, et al. (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271: 840-844.
21. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, et al. (2004) Obesity and the risk of new-onset atrial fibrillation. JAMA 292: 2471-2477. (Pubitemid 39552671)
22. Hense HW, Gneiting B, Muscholl M, Broeckel U, Kuch B, et al. (1998) The associations of body size and body composition with left ventricular mass: impacts for indexation in adults. J Am Coll Cardiol 32: 451-457. (Pubitemid 28396496)
23. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, et al. (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20: 1251-1260.
24. Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, et al. (2013) Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 10: 90-100.
25. Zhou ZQ, Hu DY, Chen J, Zhang RH, Li KB, et al. (2003) An epidemiological survey of atrial fibrillation in China. Chin J Intern Med (Chin) 43: 491-494.
26. Rutten FH, Gramer MJM, Zuithoff NPA, Lammers JWJ, Verweij W, et al. (2007) Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail 9: 651-659. (Pubitemid 46711268)